Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Acrivon Therapeutics, Inc.

NASDAQ: ACRV · Life Sciences · 4 alerts · CIK 1781174

Share price
$1.46Close, Nov 16
Market cap
$62.7M
Shares outstanding
42.91MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Acrivon Therapeutics, Inc. filings on SEC EDGAR ↗

4:56 PM ET 8-K
Investor Presentation

Acrivon Therapeutics Investor Presentation

Acrivon Therapeutics hosted a corporate R&D event and webcast featuring Key Opinion Leaders to introduce its new immunology and inflammation (I&I) programs, ACR-525 and a PKCθ inhibitor. The company filed a formal investor presentation deck detailing the preclinical programs and development plans for Eosinophilic esophagitis (EoE) identified via its AP3 platform.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.